{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:45:55Z","timestamp":1790397955442,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"33","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T00:00:00Z","timestamp":1498089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI 111451"],"award-info":[{"award-number":["AI 111451"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI 109925"],"award-info":[{"award-number":["AI 109925"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.vaccine.2017.06.039","type":"journal-article","created":{"date-parts":[[2017,6,28]],"date-time":"2017-06-28T23:48:31Z","timestamp":1498693711000},"page":"4177-4183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza"],"prefix":"10.1016","volume":"35","author":[{"given":"Yasuko","family":"Hatta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Boltz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Sarawar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Kawaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamuk","family":"Bilsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2017.06.039_b0005","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/viro.1998.9488","article-title":"Characterization of avian H5N1 influenza viruses from poultry in Hong Kong","volume":"252","author":"Shortridge","year":"1998","journal-title":"Virology"},{"issue":"9101","key":"10.1016\/j.vaccine.2017.06.039_b0010","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0140-6736(97)11212-0","article-title":"Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus","volume":"351","author":"Claas","year":"1998","journal-title":"Lancet"},{"issue":"9101","key":"10.1016\/j.vaccine.2017.06.039_b0015","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(98)01182-9","article-title":"Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus","volume":"351","author":"Yuen","year":"1998","journal-title":"Lancet"},{"issue":"5349","key":"10.1016\/j.vaccine.2017.06.039_b0020","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1126\/science.279.5349.393","article-title":"Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness","volume":"279","author":"Subbarao","year":"1998","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.vaccine.2017.06.039_b0025","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1086\/315137","article-title":"Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts","volume":"180","author":"Katz","year":"1999","journal-title":"J Infect Dis"},{"issue":"7403","key":"10.1016\/j.vaccine.2017.06.039_b0030","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nature10831","article-title":"Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA\/H1N1 virus in ferrets","volume":"486","author":"Imai","year":"2012","journal-title":"Nature"},{"issue":"6088","key":"10.1016\/j.vaccine.2017.06.039_b0035","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.1213362","article-title":"Airborne transmission of influenza A\/H5N1 virus between ferrets","volume":"336","author":"Herfst","year":"2012","journal-title":"Science"},{"issue":"6088","key":"10.1016\/j.vaccine.2017.06.039_b0040","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1126\/science.1222526","article-title":"The potential for respiratory droplet-transmissible A\/H5N1 influenza virus to evolve in a mammalian host","volume":"336","author":"Russell","year":"2012","journal-title":"Science"},{"issue":"42","key":"10.1016\/j.vaccine.2017.06.039_b0045","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1016\/j.vaccine.2016.08.061","article-title":"M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice","volume":"34","author":"Sarawar","year":"2016","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2017.06.039_b0050","doi-asserted-by":"crossref","first-page":"5233","DOI":"10.1128\/JVI.00049-06","article-title":"The cytoplasmic tail of the influenza A virus M2 protein plays a role in viral assembly","volume":"80","author":"Iwatsuki-Horimoto","year":"2006","journal-title":"J Virol"},{"issue":"16","key":"10.1016\/j.vaccine.2017.06.039_b0055","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.96.16.9345","article-title":"Generation of influenza A viruses entirely from cloned cDNAs","volume":"96","author":"Neumann","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2017.06.039_b0060","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1128\/JVI.01899-07","article-title":"Novel approach to the development of effective H5N1 influenza A virus vaccines: use of M2 cytoplasmic tail mutants","volume":"82","author":"Watanabe","year":"2008","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2017.06.039_b0065","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.vaccine.2017.06.039_b0070","doi-asserted-by":"crossref","unstructured":"Steel J et al. Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio 2010;1(1).","DOI":"10.1128\/mBio.00018-10"},{"issue":"5924","key":"10.1016\/j.vaccine.2017.06.039_b0075","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"issue":"16","key":"10.1016\/j.vaccine.2017.06.039_b0080","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1073\/pnas.0801367105","article-title":"Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies","volume":"105","author":"Kashyap","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2017.06.039_b0085","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1128\/JVI.67.5.2552-2558.1993","article-title":"A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains","volume":"67","author":"Okuno","year":"1993","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2017.06.039_b0090","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1473-3099(11)70240-7","article-title":"DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials","volume":"11","author":"Ledgerwood","year":"2011","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2017.06.039_b0095","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1371\/journal.pmed.0030360","article-title":"Live, attenuated influenza A H5N1 candidate vaccines provide broad cross-protection in mice and ferrets","volume":"3","author":"Suguitan","year":"2006","journal-title":"PLoS Med"},{"issue":"2","key":"10.1016\/j.vaccine.2017.06.039_b0100","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1371\/journal.pmed.0040059","article-title":"Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans","volume":"4","author":"Sandbulte","year":"2007","journal-title":"PLoS Med"},{"issue":"11","key":"10.1016\/j.vaccine.2017.06.039_b0105","doi-asserted-by":"crossref","first-page":"e7918","DOI":"10.1371\/journal.pone.0007918","article-title":"Heterosubtype neutralizing responses to influenza A (H5N1) viruses are mediated by antibodies to virus haemagglutinin","volume":"4","author":"Garcia","year":"2009","journal-title":"PLoS One"},{"issue":"42","key":"10.1016\/j.vaccine.2017.06.039_b0110","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1016\/j.vaccine.2008.07.084","article-title":"H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses","volume":"26","author":"Mahmood","year":"2008","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2017.06.039_b0115","doi-asserted-by":"crossref","first-page":"12006","DOI":"10.1128\/JVI.01847-14","article-title":"Induction of CD8 T cell heterologous protection by a single dose of single-cycle infectious influenza virus","volume":"88","author":"Guo","year":"2014","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2017.06.039_b0120","doi-asserted-by":"crossref","first-page":"e01487","DOI":"10.1128\/mBio.01487-15","article-title":"Nonreplicating influenza A virus vaccines confer broad protection against lethal challenge","volume":"6","author":"Baz","year":"2015","journal-title":"MBio"},{"issue":"1","key":"10.1016\/j.vaccine.2017.06.039_b0125","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3201\/eid1401.061283","article-title":"Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza","volume":"14","author":"Gioia","year":"2008","journal-title":"Emerg Infect Dis"},{"issue":"45","key":"10.1016\/j.vaccine.2017.06.039_b0130","doi-asserted-by":"crossref","first-page":"6330","DOI":"10.1016\/j.vaccine.2009.03.021","article-title":"Prior infection with an H1N1 swine influenza virus partially protects pigs against a low pathogenic H5N1 avian influenza virus","volume":"27","author":"Van Reeth","year":"2009","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2017.06.039_b0135","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.vaccine.2009.12.008","article-title":"Seasonal influenza vaccine elicits heterosubtypic immunity against H5N1 that can be further boosted by H5N1 vaccination","volume":"28","author":"van Maurik","year":"2010","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17308265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17308265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,11]],"date-time":"2020-10-11T03:58:24Z","timestamp":1602388704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17308265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":27,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0264410X17308265"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.06.039","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.06.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}